Mithr Women's Health
Stepwise fertility care with practical next-step guidance.
We support couples with structured fertility evaluation and treatment pathways focused on realistic outcomes.
Key questions on evaluation timelines, tests and treatment pathways.
Usually after 12 months of regular unprotected intercourse if age is under 35, and after 6 months if age is 35 or above, or earlier if known risk factors exist.
No. Male factors contribute significantly. Both partners should be evaluated together for faster and more accurate treatment planning.
Common tests include ovulation assessment, hormone profile, pelvic ultrasound, semen analysis, thyroid/prolactin checks and tubal patency assessment when indicated.
Ovulation tracking identifies the fertile window through cycle history, follicular scans and hormone cues to optimize timing of natural conception or treatment cycles.
It is serial ultrasound monitoring during a cycle to measure follicle growth, endometrial pattern and ovulation timing for precise treatment decisions.
Selected patients with ovulation disorders, mild male factor, unexplained infertility or timing issues may benefit after appropriate couple-level evaluation.
Female age has a major impact on ovarian reserve and egg quality. Earlier assessment improves treatment options and outcome planning.
Yes. PCOS, thyroid disorders, elevated prolactin and metabolic factors can affect ovulation and conception, and often improve with targeted treatment.
Weight optimization, nutrition correction, regular sleep, exercise, stress reduction, smoking/alcohol avoidance and controlled diabetes/thyroid health are important.
Referral is advised for severe male factor, tubal block, reduced ovarian reserve, advanced age, recurrent treatment failure or specific medical indications.
Duration depends on diagnosis, age and chosen pathway. Many couples need stepwise cycles with periodic review and timely escalation when required.
